{"id":60969,"date":"2020-06-02T09:08:13","date_gmt":"2020-06-02T07:08:13","guid":{"rendered":"https:\/\/cms.munich-startup.net\/?p=60969"},"modified":"2020-12-16T15:19:49","modified_gmt":"2020-12-16T14:19:49","slug":"kumovis-receives-36-million-euros-in-series-a","status":"publish","type":"post","link":"https:\/\/cms.munich-startup.net\/en\/60969\/kumovis-receives-36-million-euros-in-series-a\/","title":{"rendered":"Kumovis receives 3.6 million euros in Series A"},"content":{"rendered":"<div class=\"entry-content\">\n<p><strong>The Munich-based medtech startup Kumovis has successfully completed its Series A financing round, raising \u20ac3.6 million. Investors include High-Tech Gr\u00fcnderfonds and Ffilipa Venture Capital, which already invested in the seed phase, as well as Renolit and Solvay Ventures.<\/strong><\/p>\n\n\n\n<p>Kumovis has developed a 3D printer with an integrated cleanroom environment specifically for medical technology. This printer produces, among other things, customized implants and is suitable for the series production of medical devices made of high-performance plastics. The focus is on processing high-performance polymers such as PEEK and PPSU, which are already established in medical technology and approved for the manufacture of medical devices. In 2019, <a href=\"\/en\/day\/kumovis\/\">the startup<\/a> with the Kumovis R1, the latest model of its 3D printer. <strong>Miriam Haerst<\/strong>, Co-CEO and co-founder of Kumovis, explains:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>&quot;The flexibility of the Kumovis R1 system, which meets the requirements of medical manufacturing, is particularly beneficial for manufacturers dealing with small-batch and patient-specific products. By providing an open 3D printing system capable of processing a wide range of thermoplastic polymers, we enable our customers not only to manufacture medical products on demand, but also to 3D print them directly at the point of care. Now, we at Kumovis are excited to take the next steps together with our new and established partners.&quot;<\/p><\/blockquote>\n\n\n\n<p>Kumovis now aims to strengthen its business case and accelerate the company&#039;s sustainable development through these new partnerships. Renolit, a specialist in polymer-based components for medical devices, and Solvay, a global supplier of high-performance specialty polymers, bring the appropriate expertise to the table. <strong>Stefan Leonhardt<\/strong>, Co-CEO and co-founder of Kumovis, explains: <\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>&nbsp;\u201cWe will use the investments to enter new markets, further develop our technology, and support the medical community in bringing 3D-printed medical devices to patients.\u201d<\/p><\/blockquote>\n\n\n\n<h2 class=\"wp-block-heading\">Together with Kumovis \u201caccelerating the transition to personalized medicine\u201d<\/h2>\n\n\n\n<p><strong>St\u00e9phane Roussel<\/strong>, Managing Director of Solvay Ventures, says:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>&quot;The impressive team, as well as the product quality and performance characteristics, give us confidence that Kumovis is poised to fundamentally transform manufacturing in the demanding medical device industry. Kumovis and Solvay will work together to accelerate the transition to personalized medicine, expanding the scope of applications for high-performance specialty polymers in healthcare. Together, we have the potential to do the same in other industries.&quot; <\/p><\/blockquote>\n\n\n\n<p><strong>Thomas Sampers<\/strong>, Head of Renolit Healthcare, adds:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>\u201cThis investment is an important step for Renolit Healthcare to further its momentum toward healthcare innovation with partners and strengthen its presence in the medical device sector.\u201d<\/p><\/blockquote>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>The Munich-based medtech startup Kumovis has successfully completed its Series A financing round, raising \u20ac3.6 million. Investors include High-Tech Gr\u00fcnderfonds and Ffilipa Venture Capital, which already invested in the seed phase, as well as Renolit and Solvay Ventures. Kumovis has developed a 3D printer with an integrated cleanroom environment specifically for medical technology. This\u2026<\/p>","protected":false},"author":33,"featured_media":60970,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5633,1],"tags":[52,3367],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.1.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Kumovis erh\u00e4lt 3,6 Millionen Euro in Series-A - Munich Startup<\/title>\n<meta name=\"description\" content=\"Das M\u00fcnchner Medtech-Startup Kumovis hat seine Series-A-Finanzierungsrunde erfolgreich abgeschlossen und 3,6 Millionen Euro eingesammelt.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cms.munich-startup.net\/en\/60969\/kumovis-receives-36-million-euros-in-series-a\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kumovis erh\u00e4lt 3,6 Millionen Euro in Series-A - Munich Startup\" \/>\n<meta property=\"og:description\" content=\"Das M\u00fcnchner Medtech-Startup Kumovis hat seine Series-A-Finanzierungsrunde erfolgreich abgeschlossen und 3,6 Millionen Euro eingesammelt.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cms.munich-startup.net\/en\/60969\/kumovis-receives-36-million-euros-in-series-a\/\" \/>\n<meta property=\"og:site_name\" content=\"Munich Startup\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/munichstartup\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-06-02T07:08:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-12-16T14:19:49+00:00\" \/>\n<meta name=\"author\" content=\"Maximilian Feigl\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:site\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Maximilian Feigl\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cms.munich-startup.net\/60969\/kumovis-erhaelt-36-millionen-euro-in-series-a\/\",\"url\":\"https:\/\/cms.munich-startup.net\/60969\/kumovis-erhaelt-36-millionen-euro-in-series-a\/\",\"name\":\"Kumovis erh\u00e4lt 3,6 Millionen Euro in Series-A - Munich Startup\",\"isPartOf\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cms.munich-startup.net\/60969\/kumovis-erhaelt-36-millionen-euro-in-series-a\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cms.munich-startup.net\/60969\/kumovis-erhaelt-36-millionen-euro-in-series-a\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2020\/05\/1-kumovis-co-founders.jpg\",\"datePublished\":\"2020-06-02T07:08:13+00:00\",\"dateModified\":\"2020-12-16T14:19:49+00:00\",\"author\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/40ec2127e0b2a722f0cb734a53f43509\"},\"description\":\"Das M\u00fcnchner Medtech-Startup Kumovis hat seine Series-A-Finanzierungsrunde erfolgreich abgeschlossen und 3,6 Millionen Euro eingesammelt.\",\"breadcrumb\":{\"@id\":\"https:\/\/cms.munich-startup.net\/60969\/kumovis-erhaelt-36-millionen-euro-in-series-a\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cms.munich-startup.net\/60969\/kumovis-erhaelt-36-millionen-euro-in-series-a\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/60969\/kumovis-erhaelt-36-millionen-euro-in-series-a\/#primaryimage\",\"url\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2020\/05\/1-kumovis-co-founders.jpg\",\"contentUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2020\/05\/1-kumovis-co-founders.jpg\",\"width\":640,\"height\":458,\"caption\":\"Die Mitbegr\u00fcnder von Kumovis (von links nach rechts): Stefan Leonhardt, Dr. Miriam Haerst, Alexander Henhammer, Sebastian Pammer, Stefan Fischer.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cms.munich-startup.net\/60969\/kumovis-erhaelt-36-millionen-euro-in-series-a\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cms.munich-startup.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kumovis erh\u00e4lt 3,6 Millionen Euro in Series-A\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cms.munich-startup.net\/#website\",\"url\":\"https:\/\/cms.munich-startup.net\/\",\"name\":\"Munich Startup\",\"description\":\"Das offizielle Startup-Portal f\u00fcr M\u00fcnchen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cms.munich-startup.net\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/40ec2127e0b2a722f0cb734a53f43509\",\"name\":\"Maximilian Feigl\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/194fab98a3d18da0d43ab2b73b348908?s=96&d=blank&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/194fab98a3d18da0d43ab2b73b348908?s=96&d=blank&r=g\",\"caption\":\"Maximilian Feigl\"},\"description\":\"Maximilian Feigl berichtet seit 2020 \u00fcber das M\u00fcnchner Startup \u00d6kosystem. Dabei haben es dem studierten Politikwissenschaftler vor allem Deeptech-Themen angetan.\",\"url\":\"https:\/\/cms.munich-startup.net\/en\/author\/feigl\/\"}]}<\/script>\n<meta property=\"og:image\" content=\"https:\/\/cms.munich-startup.net\/en\/wp-content\/uploads\/2020\/05\/1-kumovis-co-founders.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"458\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kumovis receives \u20ac3.6 million in Series A - Munich Startup","description":"The Munich-based medtech startup Kumovis has successfully completed its Series A financing round and raised 3.6 million euros.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cms.munich-startup.net\/en\/60969\/kumovis-receives-36-million-euros-in-series-a\/","og_locale":"en_US","og_type":"article","og_title":"Kumovis erh\u00e4lt 3,6 Millionen Euro in Series-A - Munich Startup","og_description":"Das M\u00fcnchner Medtech-Startup Kumovis hat seine Series-A-Finanzierungsrunde erfolgreich abgeschlossen und 3,6 Millionen Euro eingesammelt.","og_url":"https:\/\/cms.munich-startup.net\/en\/60969\/kumovis-receives-36-million-euros-in-series-a\/","og_site_name":"Munich Startup","article_publisher":"https:\/\/www.facebook.com\/munichstartup\/","article_published_time":"2020-06-02T07:08:13+00:00","article_modified_time":"2020-12-16T14:19:49+00:00","author":"Maximilian Feigl","twitter_card":"summary_large_image","twitter_creator":"@munich_startup","twitter_site":"@munich_startup","twitter_misc":{"Written by":"Maximilian Feigl","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cms.munich-startup.net\/60969\/kumovis-erhaelt-36-millionen-euro-in-series-a\/","url":"https:\/\/cms.munich-startup.net\/60969\/kumovis-erhaelt-36-millionen-euro-in-series-a\/","name":"Kumovis receives \u20ac3.6 million in Series A - Munich Startup","isPartOf":{"@id":"https:\/\/cms.munich-startup.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cms.munich-startup.net\/60969\/kumovis-erhaelt-36-millionen-euro-in-series-a\/#primaryimage"},"image":{"@id":"https:\/\/cms.munich-startup.net\/60969\/kumovis-erhaelt-36-millionen-euro-in-series-a\/#primaryimage"},"thumbnailUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2020\/05\/1-kumovis-co-founders.jpg","datePublished":"2020-06-02T07:08:13+00:00","dateModified":"2020-12-16T14:19:49+00:00","author":{"@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/40ec2127e0b2a722f0cb734a53f43509"},"description":"The Munich-based medtech startup Kumovis has successfully completed its Series A financing round and raised 3.6 million euros.","breadcrumb":{"@id":"https:\/\/cms.munich-startup.net\/60969\/kumovis-erhaelt-36-millionen-euro-in-series-a\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cms.munich-startup.net\/60969\/kumovis-erhaelt-36-millionen-euro-in-series-a\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/60969\/kumovis-erhaelt-36-millionen-euro-in-series-a\/#primaryimage","url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2020\/05\/1-kumovis-co-founders.jpg","contentUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2020\/05\/1-kumovis-co-founders.jpg","width":640,"height":458,"caption":"Die Mitbegr\u00fcnder von Kumovis (von links nach rechts): Stefan Leonhardt, Dr. Miriam Haerst, Alexander Henhammer, Sebastian Pammer, Stefan Fischer."},{"@type":"BreadcrumbList","@id":"https:\/\/cms.munich-startup.net\/60969\/kumovis-erhaelt-36-millionen-euro-in-series-a\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cms.munich-startup.net\/"},{"@type":"ListItem","position":2,"name":"Kumovis erh\u00e4lt 3,6 Millionen Euro in Series-A"}]},{"@type":"WebSite","@id":"https:\/\/cms.munich-startup.net\/#website","url":"https:\/\/cms.munich-startup.net\/","name":"Munich Startup","description":"The official startup portal for Munich","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cms.munich-startup.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/40ec2127e0b2a722f0cb734a53f43509","name":"Maximilian Feigl","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/194fab98a3d18da0d43ab2b73b348908?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/194fab98a3d18da0d43ab2b73b348908?s=96&d=blank&r=g","caption":"Maximilian Feigl"},"description":"Maximilian Feigl has been reporting on the Munich startup ecosystem since 2020. The political scientist is particularly interested in deeptech topics.","url":"https:\/\/cms.munich-startup.net\/en\/author\/feigl\/"}]},"og_image":[{"width":640,"height":458,"url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2020\/05\/1-kumovis-co-founders.jpg","type":"image\/jpeg"}]},"_showyear":"","_inactive":"","_show_financing":"","_hide_on_map":"","_edit_lock":"1608128396:22","_edit_last":"22","_yoast_wpseo_focuskw":"Kumovis","_yoast_wpseo_metadesc":"Das M\u00fcnchner Medtech-Startup Kumovis hat seine Series-A-Finanzierungsrunde erfolgreich abgeschlossen und 3,6 Millionen Euro eingesammelt.","_yoast_wpseo_linkdex":"73","_thumbnail_id":"60970","wbounce_status":"default","_yoast_wpseo_primary_category":"5633","_yoast_wpseo_focuskw_text_input":"","_yoast_wpseo_content_score":"30","ms_image_format":"contentwidth","_ms_image_format":"field_5cb8587572c8b","ms_dachzeile":"","_ms_dachzeile":"field_5cd9b7f365df5","ms_bump_post_date":"","_ms_bump_post_date":"field_5d1341edcf42a","guest_author_name":"","_guest_author_name":"field_5cee78a6016f9","guest_author_image":"","_guest_author_image":"field_5cee7914016fb","guest_author_description":"","_guest_author_description":"field_5cee78dd016fa","ms_post_image_caption":"","_ms_post_image_caption":"field_5f735b0735284","ms_post_image_credit":"","_ms_post_image_credit":"field_5f735b1435285","suppress_startupbox":"","_suppress_startupbox":"","_yoast_wpseo_estimated-reading-time-minutes":"","_wp_old_date":"","_yoast_wpseo_title":"","_yoast_wpseo_wordproof_timestamp":"","footnotes":"","easy_language_simplification_original_id":"","easy_language_source_language":"","easy_language_simplification_language":"","easy_language_api":"","easy_language_prevent_automatic_mode":"","_wp_old_slug":"","_wp_trash_meta_status":"","_wp_trash_meta_time":"","easy_language_simplification_state_changed_from":"","easy_language_de_EL_changed":"","ms_competition_deadline":"","_ms_competition_deadline":"","_wpbitly":"","enclosure":"","_yoast_wpseo_meta-robots-noindex":"","_yoast_wpseo_meta-robots-nofollow":"","wbounce_template":"","wbounce_title":"","wbounce_text":"","wbounce_cta":"","wbounce_url":"","wbounce_override":"","_yoast_wpseo_opengraph-title":"","_yoast_wpseo_opengraph-description":"","_oembed_7131efca3705e16bd9da2c41df237660":"","_oembed_time_7131efca3705e16bd9da2c41df237660":"","_pprredirect_type":"","_pprredirect_url":"","_yoast_wpseo_opengraph-image":"","_yoast_wpseo_opengraph-image-id":"","_newsletterglue":"","easy_language_text_language":"","_wp_desired_post_slug":"","_relevanssi_noindex_reason":"","_links":{"self":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/60969"}],"collection":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/users\/33"}],"replies":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/comments?post=60969"}],"version-history":[{"count":2,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/60969\/revisions"}],"predecessor-version":[{"id":61017,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/60969\/revisions\/61017"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media\/60970"}],"wp:attachment":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media?parent=60969"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/categories?post=60969"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/tags?post=60969"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}